Hyperbaric oxygen therapy achieves high remission rates for ulcerative colitis
Hyperbaric oxygen therapy achieves high remission rates for ulcerative colitis
Understanding ulcerative colitis and how oxygen therapy promotes remission
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes swelling and ulcers in the lining of the colon and rectum. It leads to bloody diarrhea, abdominal pain, urgency, frequent bathroom trips, fatigue and weight loss. UC is an autoimmune condition where the immune system mistakenly attacks the colon lining, causing ongoing inflammation and tissue damage.
Standard treatments include anti-inflammatory medications, immunosuppressants, biologics and in severe cases, surgical removal of the colon (colectomy). However, many patients experience treatment-resistant flares that do not respond adequately to conventional therapy. HBOT offers a powerful complementary approach by directly reducing intestinal inflammation, promoting mucosal healing and supporting the immune system's ability to resolve acute flares without escalating to surgery.
Bloody diarrhea, abdominal pain and cramping
Urgency, frequent bathroom trips and incontinence
Fatigue, weight loss and nutritional deficiencies
Risk of hospitalization and colectomy during severe flares
How pressurized oxygen calms UC flares and promotes lasting remission
HBOT addresses ulcerative colitis through multiple mechanisms that reduce inflammation, heal damaged tissue and support immune function.
Faster symptom relief during acute flares
Reduces hospitalization and colectomy risk
Reduces harmful inflammation and inflammatory markers
Enhances immune system response
Promotes mucosal healing in the colon
Safe and cost-effective adjunct therapy
For Providers
Clinical evidence for HBOT in ulcerative colitis treatment
Hyperbaric oxygen therapy has demonstrated significant benefits for ulcerative colitis through multiple clinical pathways that address acute flares and promote sustained remission.
Acute flare resolution: HBOT has emerged as a game-changer for acute UC flares, with clinical data showing high remission rates in patients with severe, treatment-resistant disease. By rapidly reducing intestinal inflammation and promoting mucosal healing, HBOT can resolve flares that have not responded to standard medical therapy.
Reduction in surgical intervention: Studies demonstrate that HBOT reduces re-hospitalization rates and colectomy risk in UC patients. By effectively managing acute flares, HBOT helps patients avoid the need for emergency surgical colon removal, preserving bowel function and quality of life.
Anti-inflammatory mechanisms: HBOT decreases inflammatory markers including C-reactive protein and pro-inflammatory cytokines while enhancing the anti-inflammatory immune response. It down-regulates the overactive immune pathways driving UC inflammation without the side effects of systemic immunosuppression.
Mucosal healing: The hypoxic environment in inflamed UC tissue impairs mucosal repair. HBOT delivers concentrated oxygen directly to the colon wall, supporting epithelial regeneration, angiogenesis and tissue repair. This mucosal healing correlates with sustained clinical remission.
Safety and cost-effectiveness: HBOT is safe, well-tolerated and has minimal side effects in UC patients. The cost savings from reduced hospitalization and avoided surgery make HBOT a cost-effective addition to standard UC management, particularly for patients with severe or refractory disease.
Delayed Radiation Injury (Soft Tissue and Bony Necrosis)
The nature of delayed radiation injury, the mechanisms whereby hyperbaric oxygen is effective, clinical results, the effects of hyperbaric oxygen on cancer growth and future areas for research will be discussed.
Hyperbaric oxygen is among the most studied and frequently reported applications in the treatment of delayed radiation injuries. This application of hyperbaric oxygen to the treatment and prevention of delayed radiation injury will be the topic of this chapter. The management of delayed radiation injury, especially when bone necrosis is present, requires mult-disciplinary management. The nature of delayed radiation injury, the mechanisms whereby hyperbaric oxygen is effective, clinical results, the effects of hyperbaric oxygen on cancer growth and future areas for research will be discussed.Clinical Effectiveness of Hyperbaric Oxygen Therapy in Complex Wounds
Hyperbaric oxygen therapy has a role in modern medical practice. In most cases, it is safe and severe side effects are rare. There are many indications for HBO treatment.
The results suggest that HBO has been shown to be an effective method for treating complex wounds. It significantly improved wound healing. However, HBO does not replace quality wound care. HBO should be used in addition to, but not as a replacement of aggressive wound treatment.Hyperbaric oxygen therapy for the management of chronic wounds: patient selection and perspectives.
The use of HBOT for chronic, problem wounds is best defined for DFUs, but there is a sound fundamental basis for its use for some other chronic wound types.
The Undersea and Hyperbaric Medical Society includes “select problem wounds” as an accepted indication for the use of hyperbaric oxygen (HBO2), however, the treatment of diabetic foot ulcers (DFUs) has dominated any discussions of problem wounds because of the prevalence of DFUs in today’s patient population and the reimbursement available for their treatment. Other wound types (eg, calciphylaxis ulcers, sickle cell ulcers, and pyoderma gangrenosum) that have well-deserved reputations as problem wounds have been infrequently treated with HBO2. While there are sound fundamental reasons why additional oxygen may have benefits in the treatment of these wounds, the challenge is finding enough high quality evidence to support routine use of HBO2.Your path from UC flares to sustained remission
We design a personalized HBOT protocol based on your UC severity, flare frequency and treatment history.
Comprehensive UC assessment and treatment planning
Our medical team reviews your UC history, current medications, disease activity and any complications to design a targeted HBOT plan coordinated with your gastroenterologist.
Comfortable daily sessions in our pressurized chambers
You breathe 100% oxygen in a pressurized chamber for approximately 90 minutes per session. UC protocols typically involve 20 to 40 sessions depending on disease severity.
Measurable reduction in inflammation and symptoms
We track symptom improvement and coordinate with your GI team on lab markers. Most patients experience progressive reduction in bleeding, diarrhea and pain.
Frequently Asked Questions
Answers to the questions patients ask most about hyperbaric oxygen therapy for ulcerative colitis treatment.
HBOT delivers concentrated oxygen to the inflamed colon lining, rapidly reducing inflammation, promoting mucosal healing and supporting immune rebalancing. It decreases inflammatory markers, helps resolve acute flares and reduces the risk of hospitalization and surgical colon removal.
Take control of your ulcerative colitis
Schedule a free consultation to discuss how hyperbaric oxygen therapy can help you achieve remission and reduce your risk of hospitalization and surgery.
